Market Cap

Conversion Labs, Inc. Market Capitalization:

€37.57 Billion

EUR as of July 1, 2025

US$44.36 Billion

business Conversion Labs, Inc. Company Profile

Conversion Labs, Inc. Main Stock Listing

NASDAQ: CVLB

Market Capitalization History of Conversion Labs, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Pharmaceutical Retailers
Company Market Cap (USD)
Walgreens Boots Alliance, Inc. $9.95 B
Alibaba Health Information Technology Ltd $9.27 B
Matsumotokiyoshi Holdings Co. Ltd $8.19 B
Clicks Group Ltd $5.18 B
COSMOS Pharmaceutical Corp $5.14 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Conversion Labs, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 €35.62 B -42.02%
Jan. 1, 2024 €61.43 B -20.41%
Jan. 1, 2023 €77.19 B 22.43%
Jan. 1, 2022 €63.05 B 0.74%
Jan. 1, 2021 €62.58 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Conversion Labs, Inc. Categories

United States languages Healthcare languages Pharmaceutical Retailers
United States Healthcare United States Pharmaceutical Retailers

Stocks & Indices

Conversion Labs, Inc. has the following listings and related stock indices.


Stock: NASDAQ: CVLB

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.